NCT02273063 - rTMS for PTSD Comorbid With Major Depressive Disorder | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

April 22, 2016

Study Completion Date

April 22, 2016

Conditions

Posttraumatic Stress DisorderMajor Depressive DisorderTranscranial Magnetic Stimulation, Repetitive

Interventions

DEVICE

Transcranial Magnetic Stimulation (TMS)

Up to 40 sessions of TMS delivered with the first 35 sessions delivered over 7 weeks, and final 5 treatments delivered in taper schedule over 3 weeks. Treatment is adjunct to ongoing stable pharmacotherapy.

Trial Locations (2)

02906

Butler Hospital, Providence

02908

Providence VA Medical Center, Providence